Solasia Pharma Reduces China Operations, Transfers Drug Rights to Lee’s
Japan-based Solasia Pharma KK (TYO: 4597) announced that it will reduce its direct operations in...
HKG: 0950
Lee’s Pharmaceutical Wins NMPA Approval for ALS Drug Teglutik
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) has announced receiving market approval from the National...